Cargando…

Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis

BACKGROUND: Anti-Wolbachia treatment with doxycycline is effective in sterilising and killing adult Onchocerca volvulus nematodes, proving superior to ivermectin and of great potential as an alternative approach for the treatment and control of onchocerciasis, particularly in areas of Loa loa co-end...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamarozzi, Francesca, Tendongfor, Nicholas, Enyong, Peter A, Esum, Mathias, Faragher, Brian, Wanji, Samuel, Taylor, Mark J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350421/
https://www.ncbi.nlm.nih.gov/pubmed/22433114
http://dx.doi.org/10.1186/1756-3305-5-53
_version_ 1782232659997491200
author Tamarozzi, Francesca
Tendongfor, Nicholas
Enyong, Peter A
Esum, Mathias
Faragher, Brian
Wanji, Samuel
Taylor, Mark J
author_facet Tamarozzi, Francesca
Tendongfor, Nicholas
Enyong, Peter A
Esum, Mathias
Faragher, Brian
Wanji, Samuel
Taylor, Mark J
author_sort Tamarozzi, Francesca
collection PubMed
description BACKGROUND: Anti-Wolbachia treatment with doxycycline is effective in sterilising and killing adult Onchocerca volvulus nematodes, proving superior to ivermectin and of great potential as an alternative approach for the treatment and control of onchocerciasis, particularly in areas of Loa loa co-endemicity. Nevertheless, the length of the required treatment poses potential logistical problems and risk of poor compliance, raising a barrier to the use of doxycycline in Mass Drug Administration (MDA) strategies. In 2007 and 2008 a feasibility trial of community-directed treatment with doxycycline was carried out in two health districts in Cameroon, co-endemic for O. volvulus and L. loa. With 17,519 eligible subjects, the therapeutic coverage was 73.8% with 97.5% compliance, encouraging the feasibility of using doxycycline community-directed delivery in restricted populations of this size. The current study evaluated the effectiveness of this community-directed delivery of doxycycline four years after delivery. FINDINGS: Infection with O. volvulus was evaluated by skin biopsy and nodule palpation. Of the 507 subjects recruited, 375 had completed the treatment with doxycycline followed by one or two rounds of annual ivermectin MDA and 132 received one or two rounds of annual ivermectin MDA alone. Statistically significant lower microfilarial prevalence (17.0% [doxycycline plus ivermectin group], 27.0% [ivermectin only group], p = 0.014) and load (p = 0.012) were found in people that had received doxycycline followed by ivermectin compared to those who received ivermectin only. CONCLUSIONS: This study demonstrates the long-term effectiveness of doxycycline treatment delivered with a community-directed strategy even when evaluated four years after delivery in an area of ongoing transmission. This finding shows that a multi-week course of treatment is not a barrier to community-delivery of MDA in restricted populations of this size and supports its implementation to compliment existing control strategies for onchocerciasis, where needed.
format Online
Article
Text
id pubmed-3350421
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33504212012-05-12 Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis Tamarozzi, Francesca Tendongfor, Nicholas Enyong, Peter A Esum, Mathias Faragher, Brian Wanji, Samuel Taylor, Mark J Parasit Vectors Short Report BACKGROUND: Anti-Wolbachia treatment with doxycycline is effective in sterilising and killing adult Onchocerca volvulus nematodes, proving superior to ivermectin and of great potential as an alternative approach for the treatment and control of onchocerciasis, particularly in areas of Loa loa co-endemicity. Nevertheless, the length of the required treatment poses potential logistical problems and risk of poor compliance, raising a barrier to the use of doxycycline in Mass Drug Administration (MDA) strategies. In 2007 and 2008 a feasibility trial of community-directed treatment with doxycycline was carried out in two health districts in Cameroon, co-endemic for O. volvulus and L. loa. With 17,519 eligible subjects, the therapeutic coverage was 73.8% with 97.5% compliance, encouraging the feasibility of using doxycycline community-directed delivery in restricted populations of this size. The current study evaluated the effectiveness of this community-directed delivery of doxycycline four years after delivery. FINDINGS: Infection with O. volvulus was evaluated by skin biopsy and nodule palpation. Of the 507 subjects recruited, 375 had completed the treatment with doxycycline followed by one or two rounds of annual ivermectin MDA and 132 received one or two rounds of annual ivermectin MDA alone. Statistically significant lower microfilarial prevalence (17.0% [doxycycline plus ivermectin group], 27.0% [ivermectin only group], p = 0.014) and load (p = 0.012) were found in people that had received doxycycline followed by ivermectin compared to those who received ivermectin only. CONCLUSIONS: This study demonstrates the long-term effectiveness of doxycycline treatment delivered with a community-directed strategy even when evaluated four years after delivery in an area of ongoing transmission. This finding shows that a multi-week course of treatment is not a barrier to community-delivery of MDA in restricted populations of this size and supports its implementation to compliment existing control strategies for onchocerciasis, where needed. BioMed Central 2012-03-20 /pmc/articles/PMC3350421/ /pubmed/22433114 http://dx.doi.org/10.1186/1756-3305-5-53 Text en Copyright ©2012 Tamarozzi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Tamarozzi, Francesca
Tendongfor, Nicholas
Enyong, Peter A
Esum, Mathias
Faragher, Brian
Wanji, Samuel
Taylor, Mark J
Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
title Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
title_full Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
title_fullStr Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
title_full_unstemmed Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
title_short Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
title_sort long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350421/
https://www.ncbi.nlm.nih.gov/pubmed/22433114
http://dx.doi.org/10.1186/1756-3305-5-53
work_keys_str_mv AT tamarozzifrancesca longtermimpactoflargescalecommunitydirecteddeliveryofdoxycyclineforthetreatmentofonchocerciasis
AT tendongfornicholas longtermimpactoflargescalecommunitydirecteddeliveryofdoxycyclineforthetreatmentofonchocerciasis
AT enyongpetera longtermimpactoflargescalecommunitydirecteddeliveryofdoxycyclineforthetreatmentofonchocerciasis
AT esummathias longtermimpactoflargescalecommunitydirecteddeliveryofdoxycyclineforthetreatmentofonchocerciasis
AT faragherbrian longtermimpactoflargescalecommunitydirecteddeliveryofdoxycyclineforthetreatmentofonchocerciasis
AT wanjisamuel longtermimpactoflargescalecommunitydirecteddeliveryofdoxycyclineforthetreatmentofonchocerciasis
AT taylormarkj longtermimpactoflargescalecommunitydirecteddeliveryofdoxycyclineforthetreatmentofonchocerciasis